Veloxis Pharmaceuticals announces a restructuring of the company to support ... MarketWatch (press release) Tacrolimus is a leading immunosuppression drug used for the prevention of transplant allograft rejection after organ transplantation. LCP-Tacro(TM) is being developed as a once-daily tablet version of tacrolimus, with improved bioavailability, ... |
